AtaiBeckley (ATAI) Convertible Debt (2020 - 2022)

AtaiBeckley (ATAI) reported Convertible Debt of $380000.0 for Q3 2022, down 52.5% on a YoY basis from $800000.0 in Q3 2021, and down 38.61% sequentially from $619000.0 in Q2 2022.

AtaiBeckley (ATAI) Convertible Debt (2020 - 2022) Analysis & Trends

AtaiBeckley (ATAI) has 3 years of Convertible Debt data on file, last reported at $380000.0 in Q3 2022.

  • For the quarter ending Q3 2022, Convertible Debt fell 52.5% year-over-year to $380000.0; the trailing twelve-month figure through Sep 2022 stood at $380000.0 (down 52.5% YoY), and the FY2021 full-year result was $743000.0, down 38.03% from the prior year.
  • Convertible Debt retreated to $380000.0 in Q3 2022, from $619000.0 in the prior quarter.
  • In the past five years, Convertible Debt ranged from a high of $1.2 million in Q4 2020 to a low of $380000.0 in Q3 2022.
  • A 3-year average of $806000.0 and a median of $743000.0 in 2021 frame the typical range for Convertible Debt.
  • Across the five-year window, Convertible Debt tumbled 38.03% in 2021 and tumbled 52.5% in 2022, its largest moves.
  • Tracing ATAI's Convertible Debt over 3 years: stood at $1.2 million in 2020, then slumped by 38.03% to $743000.0 in 2021, then slumped by 48.86% to $380000.0 in 2022.
  • Business Quant data shows ATAI's Convertible Debt at $380000.0 in Q3 2022, $619000.0 in Q2 2022, and $725000.0 in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 AtaiBeckley 2.56 Bn 2.56 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2022 380,000.00
Jun 30, 2022 619,000.00
Mar 31, 2022 725,000.00
Dec 31, 2021 743,000.00
Sep 30, 2021 800,000.00
Jun 30, 2021 1.18 Mn
Dec 31, 2020 1.20 Mn